Health Technology
Bulgarian companies developing health technologies
Developing medical devices, diagnostics, and healthcare software platforms defines the health technology sector. Regulatory approval timelines and shifting Medicare reimbursement models constantly inject liquidity into these equities. Currently, Sopharma AD dominates trading volume, whereas Synthetica AD logs the strongest 24-hour performance. The table below organizes vital technical and fundamental data points.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|
 LLYEli Lilly and Company | 1.19 T EUR | 1,228.4 EUR | −4.60% | 0 | — | 45.72 | 26.87 EUR | +55.94% | 0.47% | Strong buy |
 JNJJohnson & Johnson | 592.45 B EUR | 243.05 EUR | −2.88% | 0 | — | 41.77 | 5.82 EUR | −34.10% | 1.91% | Buy |
 4ABAbbVie, Inc. | 464.16 B EUR | 258.10 EUR | −3.44% | 0 | — | 50.32 | 5.13 EUR | +354.14% | 2.35% | Buy |
 6MKMerck & Co., Inc. | 330.4 B EUR | 131.38 EUR | −3.35% | 0 | — | 151.99 | 0.86 EUR | −86.58% | 2.26% | Buy |
 ZEGAstraZeneca PLC | 260.84 B EUR | 165.60 EUR | −3.36% | 0 | — | 26.86 | 6.17 EUR | +16.68% | 1.70% | Buy |
 ABLAbbott Laboratories | 178.02 B EUR | 99.54 EUR | −4.29% | 0 | — | 41.63 | 2.39 EUR | −64.81% | 2.18% | Buy |
 NOVNovo Nordisk A/S Class B | 168.68 B EUR | 35.975 EUR | −1.73% | 16 | 0.52 | 10.58 | 3.40 EUR | +9.26% | 4.10% | Neutral |
 PFEPfizer Inc. | 156.31 B EUR | 28.005 EUR | +3.47% | 0 | 0.00 | 45.37 | 0.62 EUR | −57.78% | 5.59% | Neutral |
 2M6Medtronic Plc | 119.58 B EUR | 92.16 EUR | −2.41% | 0 | — | 26.14 | 3.53 EUR | +11.12% | 2.72% | Buy |
 SYKStryker Corporation | 115.16 B EUR | 277.5 EUR | −0.89% | 0 | — | 33.49 | 8.29 EUR | +27.68% | 1.04% | Buy |
 SNWSanofi SA | 100.88 B EUR | 82.86 EUR | −2.38% | 0 | 0.00 | 24.89 | 3.33 EUR | −35.60% | 4.90% | Buy |
 0QFModerna, Inc. | 91.88 B EUR | 194.700 EUR | −1.54% | 0 | — | — | −6.99 EUR | −9.55% | 0.00% | Neutral |
 ESLEssilorLuxottica SA | 87.56 B EUR | 192.70 EUR | +0.05% | 0 | — | 36.01 | 5.35 EUR | +3.83% | 2.12% | Buy |
 MRKMerck KGaA | 65.41 B EUR | 147.95 EUR | −1.14% | 0 | — | 27.14 | 5.45 EUR | −17.22% | 1.46% | Buy |
 BSXBoston Scientific Corporation | 59.15 B EUR | 40.860 EUR | +0.26% | 0 | — | 19.60 | 2.09 EUR | +30.86% | 0.00% | Buy |
 BAYNBayer AG | 53.29 B EUR | 54.52 EUR | −3.26% | 0 | 0.00 | — | −1.77 EUR | +49.15% | 0.20% | Buy |
 SHLSiemens Healthineers AG | 50.04 B EUR | 44.28 EUR | −1.18% | 0 | 0.00 | 22.43 | 1.97 EUR | +2.35% | 2.23% | Buy |
 ZOEZoetis, Inc. Class A | 32.83 B EUR | 76.60 EUR | +0.21% | 0 | — | 14.39 | 5.32 EUR | +7.88% | 2.38% | Neutral |
 KN8Krka, d. d., Novo mesto | 7.73 B EUR | 244.0 EUR | −2.01% | 0 | — | 17.73 | 13.77 EUR | +10.70% | 3.67% | Buy |
 AFXCarl Zeiss Meditec AG | 3.2 B EUR | 34.98 EUR | −3.05% | 0 | — | 32.28 | 1.08 EUR | −38.81% | 1.54% | Sell |
 SFASopharma AD | 1.68 B EUR | 3.33 EUR | +0.91% | 16.3 K | 0.36 | 22.29 | 0.15 EUR | +52.60% | 2.97% | No rating |
 NVV1Novavax, Inc. | 1.56 B EUR | 9.27 EUR | +2.54% | 0 | — | — | −1.33 EUR | −169.59% | 0.00% | Buy |
 038NovoCure Ltd. | 1.52 B EUR | 12.150 EUR | +1.63% | 0 | — | — | −0.94 EUR | +31.50% | 0.00% | Buy |
 EUZEckert & Ziegler SE | 876.04 M EUR | 13.80 EUR | −2.89% | 0 | — | 17.44 | 0.79 EUR | +35.27% | 1.57% | Strong buy |
 AYJValneva SE | 481.73 M EUR | 2.479 EUR | −2.32% | 0 | — | — | −0.90 EUR | −117.39% | 0.00% | Strong buy |
| SSYNSynthetica AD | 154.5 M EUR | 51.5 EUR | +11.96% | 3 | 0.02 | 33.27 | 1.55 EUR | +879.62% | 0.00% | No rating |
| EETREtropal AD | 15 M EUR | 3.00 EUR | 0.00% | 40 | 1.25 | — | −0.02 EUR | −253.70% | 0.00% | No rating |
 PHRMPharmhold AD | — | 0.540 EUR | 0.00% | 0 | — | — | — | — | — | No rating |